These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. Mol Cell; 2007 Jun 08; 26(5):731-43. PubMed ID: 17540598 [Abstract] [Full Text] [Related]
3. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression. Novello C, Pazzaglia L, Conti A, Quattrini I, Pollino S, Perego P, Picci P, Benassi MS. PLoS One; 2014 Jun 08; 9(12):e114757. PubMed ID: 25490093 [Abstract] [Full Text] [Related]
4. Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network. Samuel N, Wilson G, Id Said B, Pan A, Deblois G, Fischer NW, Alexandrova R, Casallo G, Paton T, Lupien M, Gariepy J, Merico D, Hudson TJ, Malkin D. Oncotarget; 2016 Aug 02; 7(31):49611-49622. PubMed ID: 27391063 [Abstract] [Full Text] [Related]
5. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing. Cabrita MA, Vanzyl EJ, Hamill JD, Pan E, Marcellus KA, Tolls VJ, Alonzi RC, Pastic A, Rambo TM, Sayed H, McKay BC. PLoS One; 2016 Aug 02; 11(2):e0148529. PubMed ID: 26840126 [Abstract] [Full Text] [Related]
6. Restoration of miR-34a in p53 deficient cells unexpectedly promotes the cell survival by increasing NFκB activity. Tan J, Fan L, Mao JJ, Chen B, Zheng L, Zhang T, Li T, Duan J, Duan Y, Jin Z, Kuang W. J Cell Biochem; 2012 Sep 02; 113(9):2903-8. PubMed ID: 22531959 [Abstract] [Full Text] [Related]
7. Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells. Chakraborty S, Mazumdar M, Mukherjee S, Bhattacharjee P, Adhikary A, Manna A, Chakraborty S, Khan P, Sen A, Das T. FEBS Lett; 2014 Feb 14; 588(4):549-59. PubMed ID: 24444609 [Abstract] [Full Text] [Related]
8. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue YF, Li G, Lu X, Sun Z, Tang KF. Carcinogenesis; 2012 Mar 14; 33(3):519-28. PubMed ID: 22198213 [Abstract] [Full Text] [Related]
9. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G, Hermeking H. Cell Cycle; 2007 Jul 01; 6(13):1586-93. PubMed ID: 17554199 [Abstract] [Full Text] [Related]
10. Upregulation of miR-34a-5p antagonizes AFB1-induced genotoxicity in F344 rat liver. Liu C, Yu H, Zhang Y, Li D, Xing X, Chen L, Zeng X, Xu D, Fan Q, Xiao Y, Chen W, Wang Q. Toxicon; 2015 Nov 01; 106():46-56. PubMed ID: 26385312 [Abstract] [Full Text] [Related]
11. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis. Wang DT, Ma ZL, Li YL, Wang YQ, Zhao BT, Wei JL, Qi X, Zhao XT, Jin YX. Oncol Rep; 2013 Jul 01; 30(1):492-8. PubMed ID: 23670238 [Abstract] [Full Text] [Related]
12. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Luan S, Sun L, Huang F. Arch Med Res; 2010 Feb 01; 41(2):67-74. PubMed ID: 20470934 [Abstract] [Full Text] [Related]
13. Expression level of miR-34a rather than P53 gene status correlates with mutability in related human lymphoblast cell lines. Chen X, Yan J, Chen T. Mol Carcinog; 2012 Aug 01; 51(8):674-7. PubMed ID: 21809390 [Abstract] [Full Text] [Related]
14. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. Castro RE, Ferreira DM, Afonso MB, Borralho PM, Machado MV, Cortez-Pinto H, Rodrigues CM. J Hepatol; 2013 Jan 01; 58(1):119-25. PubMed ID: 22902550 [Abstract] [Full Text] [Related]
15. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Georges SA, Biery MC, Kim SY, Schelter JM, Guo J, Chang AN, Jackson AL, Carleton MO, Linsley PS, Cleary MA, Chau BN. Cancer Res; 2008 Dec 15; 68(24):10105-12. PubMed ID: 19074876 [Abstract] [Full Text] [Related]
16. miR-23a binds to p53 and enhances its association with miR-128 promoter. Li J, Aung LH, Long B, Qin D, An S, Li P. Sci Rep; 2015 Nov 10; 5():16422. PubMed ID: 26553132 [Abstract] [Full Text] [Related]
17. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation. Rizzo M, Mariani L, Cavallini S, Simili M, Rainaldi G. Nucleic Acid Ther; 2012 Aug 10; 22(4):283-8. PubMed ID: 22830357 [Abstract] [Full Text] [Related]
18. miR-34 and p53: New Insights into a Complex Functional Relationship. Navarro F, Lieberman J. PLoS One; 2015 Aug 10; 10(7):e0132767. PubMed ID: 26177460 [Abstract] [Full Text] [Related]
19. A microRNA component of the p53 tumour suppressor network. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ. Nature; 2007 Jun 28; 447(7148):1130-4. PubMed ID: 17554337 [Abstract] [Full Text] [Related]
20. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T, Ito M. Biochem Biophys Res Commun; 2008 Dec 05; 377(1):114-9. PubMed ID: 18834855 [Abstract] [Full Text] [Related] Page: [Next] [New Search]